Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Myelination of axons by oligodendrocytes enables rapid impulse propagation in the central nervous system. But long-term interactions between axons and their myelin sheaths are poorly understood. Here we show that Cnp1, which encodes 2',3'-cyclic nucleotide phosphodiesterase in oligodendrocytes, is essential for axonal survival but not for myelin assembly. In the absence of glial cyclic nucleotide phosphodiesterase, mice developed axonal swellings and neurodegeneration throughout the brain, leading to hydrocephalus and premature death. But, in contrast to previously studied myelin mutants, the ultrastructure, periodicity and physical stability of myelin were not altered in these mice. Genetically, the chief function of glia in supporting axonal integrity can thus be completely uncoupled from its function in maintaining compact myelin. Oligodendrocyte dysfunction, such as that in multiple sclerosis lesions, may suffice to cause secondary axonal loss.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A direct role for oligodendrocytes to sustain axonal function is supported by the observation that mice lacking 2′,3′-cyclic nucleotide phosphodiesterase (CNPase) or proteolipid protein (PLP) display axonal dysfunction without demyelination in the spinal cord and brain [86,87].”
From X-linked adrenoleukodystrophy: Clinical, metabolic, genetic and pathophysiological aspects (2012) · cites this paper as [87]
Citations
Cites
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
MYELINATION IN RAT BRAIN: METHOD OF MYELIN ISOLATION1
Norton, W. T., & Poduslo, S. E. (1973) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1973.tb07519.x · Cited by 1,413
Silver Staining of Myelin by Means of Physical Development
Gallyas, F. (1979) · Neurological Research · doi:10.1080/01616412.1979.11739553 · Cited by 935
Axonal Swellings and Degeneration in Mice Lacking the Major Proteolipid of Myelin
Griffiths, I., Klugmann, M., Anderson, T., Yool, D., Thomson, C., Schwab, M. H., Schneider, A., Zimmermann, F., McCulloch, M., Nadon, N., et al. (1998) · Science · doi:10.1126/science.280.5369.1610 · Cited by 889
Self-citationRd, H. (1948) · PubMed · Cited by 872
CNS Myelin and Sertoli Cell Tight Junction Strands Are Absent in Osp/Claudin-11 Null Mice
Gow, A., Southwood, C. M., Li, J. S., Pariali, M., Riordan, G. P., Brodie, S. E., Danias, J., Bronstein, J. M., Kachar, B., & Lazzarini, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)81553-6 · Cited by 699
Gene Targeting: A Practical Approach
Hirst, M. (1994) · Journal of Medical Genetics · doi:10.1136/jmg.31.10.821-a · Cited by 585
Gene targeting: a practical approach.
Joyner, A. L. (1993) · Cited by 575
Giese, K. P., Martini, R., Lemke, G., Soriano, P., & Schachner, M. (1992) · Cell · doi:10.1016/0092-8674(92)90591-y · Cited by 502
Assembly of CNS Myelin in the Absence of Proteolipid Protein
Klugmann, M., Schwab, M. H., Pühlhofer, A., Schneider, A., Zimmermann, F., Griffiths, I. R., & Nave, K.-A. (1997) · Neuron · doi:10.1016/s0896-6273(01)80046-5 · Cited by 471
Self-citation
Cited by
Items 601–700 of 1,000
Myllykoski, M., Itoh, K., Kangas, S. M., Heape, A. M., Kang, S.-U., Lübec, G., Kursula, I., & Kursula, P. (2012) · Journal of Neurochemistry · doi:10.1111/jnc.12000 · Cited by 22
“CNPase-deficient mice develop brain axonal swellings and motor deficits with age (Lappe-Siefke et al. 2003).”
BackgroundGalvita, A., Grachev, D., Azarashvili, T., Baburina, Y. L., Krestinina, O. V., Stricker, R., & Reiser, G. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06089.x · Cited by 29
“In myelinating glia the function of CNP is crucial in maintaining axonal integrity (Lappe-Siefke et al. 2003).”
BackgroundKrajnak, K., Raju, S. G., Miller, G. R., Johnson, C., Waugh, S., Kashon, M. L., & Riley, D. A. (2016) · Journal of Toxicology and Environmental Health · doi:10.1080/15287394.2015.1104272 · Cited by 22
“CNPase is not necessarily a marker of myelin damage either, but rather may serve as a marker of axon–myelin interactions (Lappe-Siefke et al., 2003).”
BackgroundHeterogeneity in oligodendroglia: Is it relevant to mouse models and human disease?
Ornelas, I. M., McLane, L. E., Saliu, A., Evangelou, A. V., Khandker, L., & Wood, T. L. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23900 · Cited by 23
“…is essential for the restoration of normal conduction of action potentials as well as for maintenance of the axonal integrity (Griffiths et al., 1998; Garbern et al., 2002; Lappe-Siefke et al., 2003; Edgar et al., 2004), it is important to study the process of remyelination specifically.”
BackgroundRemyelination: A Potential Therapeutic Strategy for Alzheimer’s Disease?
Sun, J., Zhou, H., Bai, F., Zhang, Z., & Ren, Q. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170036 · Cited by 27
Skaper, S. D., Barbierato, M., Facci, L., Borri, M., Contarini, G., Zusso, M., & Giusti, P. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0722-0 · Cited by 22
Chang, K.-J., Agrawal, I., Vainshtein, A., Ho, W. Y., Xin, W., Tucker‐Kellogg, G., Susuki, K., Peles, E., Ling, S., & Chan, J. R. (2021) · eLife · doi:10.7554/elife.64456 · Cited by 22
“Construction of the mouse lines was described previously: Tardbpfl/fl (Chiang et al., 2010) (JAX 017591); Dhh-Cre (Jaegle et al., 2003); Mpz-Cre (P0-Cre) (Feltri et al., 1999) (JAX 017927); CnpCre (Lappe-Siefke et al., 2003); Cntnap1-/- (Caspr KO) (Gollan et al., 2003); Mpz-CreERT2 (P0CreERT2) (Leone et al., 2003).”
BackgroundInfluentialBrain patterning perturbations following PTEN loss
Veleva-Rotse, B. O., & Barnes, A. P. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00035 · Cited by 24
“…and developing dendrites of bipolar cells; P23: axons and dendrites of bipolar cells; mostly in inner nuclear layer CNP1 Goebbels et al., 2006 Lappe-Siefke et al., 2003 Targeted knock-in Exon 1 of CNP gene: ATG-Cre-PGK promoter-puromycin Adult: cerebellar white matter; CNS white matter…”
Myllykoski, M., & Kursula, P. (2010) · BMC Research Notes · doi:10.1186/1756-0500-3-12 · Cited by 22
“While myelin in CNPase-deficient mice [5] appeared normal, they develop progressive axonal neurodegenerative disease.”
BackgroundGonzález‐Fernández, E., Jeong, H., Fukaya, M., Kim, H., Khawaja, R. R., Srivastava, I. N., Waisman, A., Son, Y., & Kang, S. H. (2018) · eLife · doi:10.7554/elife.32021 · Cited by 24
“The Cnp-Cre is active in mature OLs (Lappe-Siefke et al., 2003), but it impacts only a subset of late (i.e. GPR17-expressing) OPCs during early development (Tognatta et al., 2017).”
BackgroundIncreased levels of carbonic anhydrase II in the developing Down syndrome brain
Palminiello, S., Kida, E., Kaur, K., Walus, M., Wisniewski, K. E., Wierzba‐Bobrowicz, T., Rabe, A., Albertini, G., & Golabek, A. A. (2007) · Brain Research · doi:10.1016/j.brainres.2007.11.023 · Cited by 24
Post-transcriptional regulation of myelin formation
Zearfoss, N. R., Farley, B. M., & Ryder, S. (2008) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2008.06.003 · Cited by 22
The challenges of axon survival: Introduction to the special issue on axonal degeneration
Coleman, M. P. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.06.007 · Cited by 26
Ravera, S., Morelli, A. M., & Panfoli, I. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104883 · Cited by 22
McLane, L. E., Bourne, J. N., Evangelou, A. V., Khandker, L., Macklin, W. B., & Wood, T. L. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.3454-16.2017 · Cited by 22
Sleeping Beauty Screen Identifies RREB1 and Other Genetic Drivers in Human B-cell Lymphoma
Rahrmann, E. P., Wolf, N. K., Otto, G. M., Heltemes-Harris, L. M., Ramsey, L. B., Shu, J., LaRue, R. S., Linden, M. A., Rathe, S. K., Starr, T. K., et al. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0582 · Cited by 21
“We observed a similar phenomenon in the DLBCL cell line DB, RREB1 cDNA overexpression increased Kras-4B expression, whereas shRNA knockdown increased Kras4A and significantly reduced proliferation.”
MethodInfluentialHIFα Regulates Developmental Myelination Independent of Autocrine Wnt Signaling
Zhang, S., Wang, Y., Xu, J., Kim, B., Deng, W., & Guo, F. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.0731-20.2020 · Cited by 22
Discoidin domain receptor regulates ensheathment, survival and caliber of peripheral axons
Corty, M. M., Hulegaard, A. L., Hill, J. Q., Sheehan, A. E., Aicher, S. A., & Freeman, M. R. (2022) · Development · doi:10.1242/dev.200636 · Cited by 21
Cao, J., Dwyer, J. B., Gautier, N. M., Leslie, F. M., & Li, M. D. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.08.012 · Cited by 22
“Other proteins, such as PLP1 and CNP, are less involved in myelination but help shape the underlying axon and also support axon function [19, 26].”
BackgroundMyelin: not just a conduit for conduction
Popko, B. (2003) · Nature Genetics · doi:10.1038/ng0303-327 · Cited by 21
Zhu, Q., Tan, Z., Zhao, S., Huang, H., Zhao, X., Hu, X., Zhang, Y., Shields, C. B., Uetani, N., & Qiu, M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.08.062 · Cited by 20
“2 floxed mutants were described earlier (Lu et al., 2000, 2002; Uetani et al., 2000, 2006; Qi et al., 2001; Lappe-Siefke et al., 2003; Mastracci et al., 2013).”
Adaptive autophagy reprogramming in Schwann cells during peripheral demyelination
Jo, Y. R., Oh, Y., Kim, Y. H., Shin, Y. K., Kim, H. R., Go, H., Shin, J., Park, H. J., Koh, H., Kim, J. K., et al. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04683-7 · Cited by 21
“027139, 007,909), and the tdTomato mice were crossbred with Cnp-Cre mice [14] to generate Cnp-tdTomato mice.”
MethodAlzheimer’s disease: an axonal injury disease?
Liang, D., & Zhang, Z. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1264448 · Cited by 23
Zhu, B., Zhao, C., Young, F. I., Franklin, R. J. M., & Song, B. (2014) · Current Protocols in Stem Cell Biology · doi:10.1002/9780470151808.sc02d17s31 · Cited by 20
Simvastatin interferes with process outgrowth and branching of oligodendrocytes
Smolders, I., Smets, I., Maier, O., vandeVen, M., Steels, P., & Ameloot, M. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22490 · Cited by 20
“…and membrane expansion during myelination and in maintaining axonal integrity (Sprinkle, 1989; Wilson and Brophy, 1989; Agrawal et al., 1990; De Angelis and Braun, 1994; Gravel et al., 1996; Yin et al., 1997; Lee et al., 2001, 2005; Dyer, 2002; Lappe-Siefke et al., 2003; Rasband et al., 2005).”
BackgroundLooser, Z. J., Barrett, M. J. P., Hirrlinger, J., Weber, B., & Saab, A. S. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00377 · Cited by 21
“For example, axonal metabolite dynamics could be studied in mouse mutants with oligodendrocyte- or myelinspecific defects that develop axonal pathology (Griffiths et al., 1998; Lappe-Siefke et al., 2003; Kassmann et al., 2007; Lee et al., 2012; Saab et al., 2016) to better understand whether and how axonal metabolite…”
BackgroundA principled strategy for mapping enhancers to genes
Kim, D., An, H., Shearer, R. S., Sharif, M. A., Fan, C., Choi, J., Ryu, S., & Park, Y. (2019) · Scientific Reports · doi:10.1038/s41598-019-47521-w · Cited by 20
Zhu, B., Nicholls, M., Gu, Y., Zhang, G., Zhao, C., Franklin, R. J. M., & Song, B. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111948 · Cited by 20
“Oligodendrocytes are the myelinating cells of the central nervous system (CNS), and are essential for both the high-speed conduction of action potentials [1] and the maintenance of neuronal circuitry [2].”
BackgroundAxonal Degeneration in Multiple Sclerosis: The Histopathological Evidence
Peterson, J. W., Kidd, G. J., & Trapp, B. D. (2005) · Elsevier eBooks · doi:10.1016/b978-012738761-1/50013-4 · Cited by 24
Zhou, Y., Huang, Z., Lin, B., Ma, M., Hao, Y., Liu, J., Xu, W., Huang, G., Mo, W., Wang, X., et al. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-024-01235-w · Cited by 20
Xiong, M., Chen, L.-X., Ma, S., Yang, Y., & Zhou, W. (2013) · Developmental Neuroscience · doi:10.1159/000346324 · Cited by 22
PIKE is essential for oligodendroglia development and CNS myelination
Chan, C. B., Liu, X., Zhao, L., Liu, G., Lee, C. W., Feng, Y., & Ye, K. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318185111 · Cited by 19
“Therefore, PIKE −/− mice display only poor performance in the spatial memory tasks (Morris water maze and Y-maze) (11) but not any spontaneous epilepsy or aberrant coordinated movement as observed in other mouse models of myelinopathy (30, 31).”
BackgroundClonal expansions of pathogenic CD8+ effector cells in the CNS of myelin mutant mice
Leder, C., Schwab, N., Ip, C. W., Kroner, A., Nave, K., Dornmair, K., Martini, R., & Wiendl, H. (2007) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2007.08.002 · Cited by 19
Self-citationNaureen, I., Waheed, K. A. I., Rathore, A. W., Victor, S., Mallucci, C. L., Goodden, J. R., Chohan, S. N., & Miyan, J. A. (2013) · Fluids and Barriers of the CNS · doi:10.1186/2045-8118-10-34 · Cited by 19
“CNPase-knockout mice show severe symptoms, including convulsions and ataxia, and most homozygous mice die between 6 and 12 months of age [64].”
Chew, L., Ming, X., Mcellin, B. M., Dupree, J. L., Hong, E., Catron, M. A., Fauveau, M., Nait‐Oumesmar, B., & Gallo, V. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.10.121 · Cited by 19
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript REAGENT or RESOURCE SOURCE IDENTIFIER 10X Transfer Buffer K-D Medical Cat# RGF-3395 20X TBS K-D Medical Cat# RGF-3346 10X TBE K-D Medical Cat# RGE-3330 20X SSC K-D Medical Cat# RGF-3240 Triton X-100 Sigma Aldrich Cat# T8787 CAS:9002–93-1 T…”
BackgroundMethodInfluentialBachstetter, A. D., Webster, S. J., Eldik, L. J. V., & Cambi, F. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-146 · Cited by 22
“The PLP-ISEdel mouse was generated to investigate the mechanism by which loss of the intron 3 splicing enhancer leads to the progressive neurological disability, demyelination, and axonal loss in the PMD patients with this PLP1 gene mutation [35].”
InfluentialShi, Q., Saifetiarova, J., Taylor, A. M., & Bhat, M. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00201 · Cited by 18
“Cnp-Cre mouse was kindly provided by the Nave laboratory (Lappe-Siefke et al., 2003).”
MethodStone, S., Wu, S., Nave, K., & Lin, W. (2020) · JCI Insight · doi:10.1172/jci.insight.132364 · Cited by 19
“Genotypes were determined by PCR from DNA extracted from tail tips as described in previous papers (25, 28, 48, 60).”
BackgroundMethodSelf-citationProgressive axonopathy when oligodendrocytes lack the myelin protein CMTM5
Buscham, T. J., Eichel-Vogel, M. A., Steyer, A. M., Jahn, O., Strenzke, N., Dardawal, R., Memhave, T. R., Siems, S. B., Müller, C., Meschkat, M., et al. (2022) · eLife · doi:10.7554/elife.75523 · Cited by 18
Self-citationEsposito, C., Scrima, M., Carotenuto, A., Tedeschi, A., Rovero, P., D’Errico, G., Malfitano, A. M., Bifulco, M., & D’Ursi, A. M. (2007) · Biochemistry · doi:10.1021/bi701474t · Cited by 19
Myllykoski, M., Raasakka, A., Lehtimäki, M., Han, H., Kursula, I., & Kursula, P. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.06.012 · Cited by 18
“A genetic knockout of CNPase results in axonal degeneration, incorrect local structures in myelin, and an increase in 2′,3′-cyclic AMP (2′,3′-cAMP) in the brain after injury [31] [32] [33] [34] .”
Mouse knockout models for HIV-1 restriction factors
Rehwinkel, J. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1646-8 · Cited by 21
Modeling the natural history of Pelizaeus–Merzbacher disease
Mayer, J. A., Griffiths, I. R., Goldman, J. E., Smith, C. M., Cooksey, E., Radcliff, A. B., & Duncan, I. D. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.12.023 · Cited by 18
“It is known that mice with deficiency in PLP or another myelin protein, CNP, show marked axon changes at late or early onset respectively (Lappe-Siefke et al., 2003; Edgar et al., 2009).”
Self-citationAubourg, P. R. (2007) · Nature Genetics · doi:10.1038/ng0807-936 · Cited by 19
Maintenance mechanisms of circuit-integrated axons
Mariano, V., Domıńguez-Iturza, N., Neukomm, L. J., & Bagni, C. (2018) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2018.08.007 · Cited by 18
Oligodendroglial glycolipids in (Re)myelination: implications for multiple sclerosis research
Nowack, L., Teschers, C. S., Albrecht, S., & Gilmour, R. (2021) · Natural Product Reports · doi:10.1039/d0np00093k · Cited by 18
Ichinose, M., Kamei, Y., Iriyama, T., Imada, S., Seyama, T., Toshimitsu, M., Asou, H., Yamamoto, M., & Fujii, T. (2014) · Journal of Neuroscience Research · doi:10.1002/jnr.23418 · Cited by 21
“Axonal damage and neuronal degeneration can be triggered secondarily by loss or dysfunction of OLs (Lappe-Siefke et al., 2003; Ghosh et al., 2011; Lee et al., 2012).”
BackgroundIn vivo labeling of peroxisomes by photoconvertible mEos2 in myelinating glia of mice
Richert, S., Kleinecke, S., Günther, J., Schaumburg, F., Edgar, J. M., Nienhaus, G. U., Nave, K., & Kassmann, C. M. (2013) · Biochimie · doi:10.1016/j.biochi.2013.10.022 · Cited by 19
Self-citationProgranulin gene variability increases the risk for primary progressive multiple sclerosis in males
Fenoglio, C., Scalabrini, D., Esposito, F., Comi, C., Cavalla, P., Riz, M. A. D., Martinelli, V., Piccio, L. M., Venturelli, E., Fumagalli, G., et al. (2010) · Genes and Immunity · doi:10.1038/gene.2010.18 · Cited by 18
ST8SIA2 promotes oligodendrocyte differentiation and the integrity of myelin and axons
Szewczyk, Ł. M., Brożko, N., Nagalski, A., Röckle, I., Werneburg, S., Hildebrandt, H., Wisniewska, M. B., & Kuźnicki, J. (2016) · Glia · doi:10.1002/glia.23048 · Cited by 19
“Additionally, oligodendroglia provide trophic support to axons independently of myelin itself (Lappe-Siefke et al., 2003; Nave 2010a; Nave 2010b; Smith et al., 2013).”
BackgroundMicro(glial)-managing executive function: white matter inflammation drives catatonia
Pease-Raissi, S. E., & Chan, J. R. (2017) · Journal of Clinical Investigation · doi:10.1172/jci98761 · Cited by 18
Usui, H., Takahashi, N., Saito, S., Ishihara, R., Aoyama, N., Ikeda, M., Suzuki, T., Kitajima, T., Yamanouchi, Y., Kinoshita, Y., et al. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.07.019 · Cited by 18
“An animal study found that CNP-deficient mice display reduction in overall brain size, enlarged ventricles, and atrophy of the corpus callosum (Lappe-Siefke et al., 2003), all of which are identical with pathological features observed in schizophrenia.”
BackgroundGuo, Y., Xiang, P., Sun, X., Liu, W., Zhou, J., Yin, B., Hou, L., Qiang, B., Li, H., Shu, P., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01742-2 · Cited by 18
An in vitro model for studying CNS white matter: functional properties and experimental approaches
Bijland, S., Thomson, G., Euston, M., Michail, K., Thümmler, K., Mücklisch, S., Crawford, C. L., Barnett, S. C., McLaughlin, M., Anderson, T. J., et al. (2019) · F1000Research · doi:10.12688/f1000research.16802.1 · Cited by 19
“…Lyons, 2017; Zalc & Fields, 2000) and the myelinating cell supports the myelinated axon throughout life (Edgar et al., 2009; Griffiths et al., 1998; Lappe-Siefke et al., 2003) by modulating axonal transport and the axonal cytoskeleton (Edgar et al., 2004; Kirkpatrick et al., 2001; Pan et al.,…”
BackgroundMethodChe, R., Tang, W., Zhang, J., Wei, Z., Zhang, Z., Huang, K., Zhao, X., Gao, J., Zhou, G., Huang, P., et al. (2009) · BMC Medical Genetics · doi:10.1186/1471-2350-10-31 · Cited by 17
“showed that CNP-deficient mice displayed a reduction in overall brain size, enlarged ventricles and corpus callosum atrophy, features which were also observed in schizophrenia patients[8].”
BackgroundJongbloets, B. C., van Gassen, K. L. I., Kan, A. A., Engberink, A. H. O. O., de Wit, M., Wolterink‐Donselaar, I. G., Koerkamp, M. J. A. G., van Nieuwenhuizen, O., Holstege, F. C. P., & Graan, P. N. E. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145247 · Cited by 19
“CNP is predominantly expressed in myelin sheaths and oligodendrocytes, although it ’ s physiological function remains ambiguous, loss of CNP affects the stability of axons [43 – 45].”
Ünlü, I., Lu, Y., & Wang, X. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004872 · Cited by 18
“Although a role for these proteins in theUPRhas not yet been demonstrated, genetic studies clearly show that mutations in CNP (26) and Clp1 (27, 28) are implicated in neurodegeneration.”
BackgroundEarly B-cell Factor gene association with multiple sclerosis in the Spanish population
Martínez, A., Mas, A. I. R., Heras, V. D. L., Arroyo, R., Fernández‐Arquero, M., de la Concha, E. G., & Urcelay, E. (2005) · BMC Neurology · doi:10.1186/1471-2377-5-19 · Cited by 22
“Axonal loss is a reliable marker of MS clinical disability [8], although the mechanism underlying axonal damage in MS remains elusive [9,10].”
BackgroundBaker, K. A., NAKASHIMA, S., & Hagg, T. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.01.018 · Cited by 17
“, 2004) as oligodendrocytes reportedly play an important role in supporting and maintaining axons (Lappe-Siefke et al., 2003; Wilkins et al., 2003; Edgar and Garbern, 2004).”
(2005) · Springer eBooks · doi:10.1007/3-540-27660-2_1 · Cited by 17
Mukherjee, C., Holubowska, A., Schwedhelm‐Domeyer, N., Mitkovski, M., Lee, S., Kannan, M., Matz, A., Vadhvani, M., & Stegmüller, J. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2133-14.2015 · Cited by 16
“A, E, I, Immunohistochemistry of paraffin sections from P16 FBXO41 / and FBXO41 / cerebella using a TUNEL detection kit (A, apoptotic marker, DNAase-treated cerebellar tissue served as positive control), IBA1 antibodies (E, activated microglia, tissue from CNPase mouse served as positive control; Lappe-Siefke et al.,…”
MethodMyelin maintenance: axonal support required
Popko, B. (2010) · Nature Neuroscience · doi:10.1038/nn0310-275 · Cited by 16
Xu, D., Liu, Z., Wang, S., Peng, Y., & Sun, X. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.06.099 · Cited by 16
Li, T., Wang, J., Wang, H., Yang, Y., Wang, S., Huang, N., Wang, F., Gao, X., Niu, J., Li, Z., et al. (2018) · Glia · doi:10.1002/glia.23450 · Cited by 17
“genes or disruption of mitochondrial function in MGCs causes axonal degeneration without degradation of the myelin sheath in adulthood (Griffiths et al., 1998; Lappe-Siefke et al., 2003; Morrison et al., 2013; Rasband et al., 2005; Viader et al., 2013).”
BackgroundBergaglio, T., Luchicchi, A., & Schenk, G. J. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.610295 · Cited by 17
“Here, earlier studies in mice revealed a crucial role of myelin molecules and oligodendroglial support in the maintenance of axonal integrity (Griffiths et al., 1998; Yin et al., 1998; Lappe-Siefke et al., 2003).”
BackgroundAbi‐Ghanem, C., Jonnalagadda, D., Chun, J. J. M., Kihara, Y., & Ranscht, B. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.908401 · Cited by 16
“Mice constitutively expressing the red fluorescent tdTomato reporter in oligodendrocytes (in text CNP1-TdTom mice) were generated by crossing CNP1Cre transgenic mice (Lappe-Siefke et al., 2003) with the Rosa26-tdTomato reporter (Jax # 007909) and used in some experiments.”
MethodRole of 2′,3′-cyclic nucleotide 3′-phosphodiesterase in the renal 2′,3′-cAMP-adenosine pathway
Jackson, E. K., Gillespie, D. G., Mi, Z., Cheng, D., Bansal, R., Janesko‐Feldman, K. L., & Kochanek, P. M. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00134.2014 · Cited by 16
Kinney, H. C., & Volpe, J. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-42876-7.00014-4 · Cited by 21
Maternal infection and white matter toxicity
Harry, G. J., Lawler, C. P., & Brunssen, S. (2006) · NeuroToxicology · doi:10.1016/j.neuro.2006.05.004 · Cited by 17
“In addition to their myelin related activities, certain oligodendrocyte/myelin related proteins contribute to the growth and maintenance of axons within white matter (Edgar et al., 2004; Lappe-Siefke et al., 2003) and synapses in gray matter (Kaifu et al.”
BackgroundHuang, L., Zhang, Y.-D., Chen, J., Fan, H., Wang, W., Wang, B., Ma, J., Li, P.-P., Pu, H.-W., Guo, X.-Y., et al. (2024) · Neural Regeneration Research · doi:10.4103/1673-5374.392889 · Cited by 16
Lee, S. W., Park, J. B., Kim, H. J., Kim, H. Y., Lee, S. Y., Chung, W. T., Shin, Y. K., Park, H. T., Rho, J. H., & Yoo, Y. H. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.07.034 · Cited by 15
Polyester Nanoparticle Encapsulation Mitigates Paclitaxel-Induced Peripheral Neuropathy
Ganugula, R., Deng, M., Arora, M., Pan, H., & Kumar, M. N. V. R. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00703 · Cited by 16
Compromised Myelin and Axonal Molecular Organization Following Adult-Onset Sulfatide Depletion
Dustin, E., Suárez‐Pozos, E., Stotesberry, C., Qiu, S., Palavicini, J. P., Han, X., & Dupree, J. L. (2023) · Biomedicines · doi:10.3390/biomedicines11051431 · Cited by 15
Padhi, B. K., Rosales, M., & Pelletier, G. (2015) · NeuroToxicology · doi:10.1016/j.neuro.2015.04.006 · Cited by 16
“Cnp regulates cytoskeletal protein dynamics to promote oligodendrocyte differentiation necessary for axonal survival (Lappe-Siefke et al., 2003).”
Hypomyelination Associated With Bovine Viral Diarrhea Virus Type 2 Infection in a Longhorn Calf
Porter, B. F., Ridpath, J. F., Calise, D. V., Payne, H. R., Janke, J. J., Baxter, D. G., & Edwards, J. F. (2010) · Veterinary Pathology · doi:10.1177/0300985810370014 · Cited by 15
“The role of CNP in myelinogenesis is questionable given that Cnp1-knockout mice develop structurally normal myelin sheaths.(16) The variation in the nervous system defects in fetuses infected transplacentally by BVDV is intriguing.”
BackgroundJoseph, S., Vingill, S., Jahn, O., Fledrich, R., Werner, H. B., Katona, I., Möbius, W., Mitkovski, M., Huang, Y., Weis, J., et al. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.3094-18.2019 · Cited by 16
“To examine the functional relevance of FBXO7 in myelinating cells in vivo, we mated Fbxo7fl/fl mice with the Cnp1-Cre driver line (Lappe-Siefke et al., 2003) to delete Fbxo7 in predominantly myelinating cells of the CNS and PNS. Genotyping of these animals revealed living conditional KO mice at the…”
BackgroundSelf-citationMillet, V., Marder, M., & Pasquini, L. A. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.11.028 · Cited by 17
Meuth, S. G., Melzer, N., Kleinschnitz, C., Budde, T., & Wiendl, H. (2008) · Der Nervenarzt · doi:10.1007/s00115-008-2599-7 · Cited by 16
Challa-Malladi, M., Chapa, G. R., Govindaraju, S., González‐García, M., & Ballestero, R. P. (2006) · Brain Research · doi:10.1016/j.brainres.2006.04.123 · Cited by 14
Ktena, N., Spyridakos, D., Georgilis, A., Kalafatakis, I., Thomoglou, E., Kolaxi, A., Nikoletopoulou, V., Savvaki, M., & Karagogeos, D. (2025) · Glia · doi:10.1002/glia.70012 · Cited by 16
Jarjour, A. A., Velichkova, A. N., Boyd, A. L., Lord, K. M., Torsney, C., Henderson, D. J., & ffrench‐Constant, C. (2020) · Glia · doi:10.1002/glia.23809 · Cited by 18
“Here adaxonal myelin proteins including the transporter MCT1 and CNPase are required for long-term metabolic support of the axon (Lappe-Siefke et al., 2003; Lee et al., 2012).”
BackgroundInfluentialRecruitment of endogenous CNS stem cells for regeneration in demyelinating disease
Murphy, N. A., & Franklin, R. J. M. (2017) · Progress in brain research · doi:10.1016/bs.pbr.2016.12.013 · Cited by 15
“As well as accelerating conduction, myelination offers trophic (Griffiths et al., 1998; Lappe-Siefke et al., 2003) and metabolic (F€unfschilling et al., 2012; Lee et al., 2012) support to the axon, making it an essential neuroprotective element of the CNS. Finally, changes in myelination throughout…”
BackgroundAhrendsen, J. T., Harlow, D. E., Finseth, L. T., Bourne, J. N., Hickey, S. P., Gould, E. A., Culp, C. M., & Macklin, W. B. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.2864-16.2017 · Cited by 15
“In an attempt to extend the survival of Shp2 conditional knock-out mice, we used the CNP-Cre transgenic mouse, in which recombination occurs later during embryonic development (Genoud et al., 2002; Lappe-Siefke et al., 2003; Furusho et al., 2006).”
MethodKlistorner, A. I., Triplett, J. D., Barnett, M. H., Yiannikas, C., Barton, J., Parratt, J., You, Y., & Graham, S. L. (2020) · Journal of Clinical Neurophysiology · doi:10.1097/wnp.0000000000000757 · Cited by 16
Solution structure of the catalytic domain of RICH protein from goldfish
Kozlov, G., Denisov, A. Y., Pomerantseva, E. A., Gravel, M., Braun, P. E., & Gehring, K. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.05707.x · Cited by 14
Self-citationC onditional knockout of TOG results in CNS hypomyelination
Maggipinto, M. J., Ford, J. A., Le, K. H., Tutolo, J. W., Furusho, M., Wizeman, J. W., Bansal, R., & Barbarese, E. (2017) · Glia · doi:10.1002/glia.23106 · Cited by 14
“Mice homozygous for the TOG floxed gene, described in Barbarese et al., (2013), were crossed with CNPcre/1 mice (Lappe-Siefke et al., 2003) to generate CNPcre/1;TOGfloxed/1.”
InfluentialTang, F., Qu, M., Wang, L., Ruan, Y., Lu, T., Zhang, H., Liu, Z., Yue, W., & Zhang, D. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.01.054 · Cited by 14
Belančić, A., Janković, T., Gkrinia, E. M. M., Kristić, I., Bumber, J. R., Rački, V., Pilipović, K., Vitezić, D., & Mršić‐Pelčić, J. (2025) · Neurology International · doi:10.3390/neurolint17030041 · Cited by 15
“This indicates that oligodendroglia, aside from myelination, ensures neuronal survival and function by providing metabolic support [76,136].”
Halford, J., Senatore, A. J., Berryman, S., Muñoz, A., Semidey, D., Doan, R. A., Coombs, A. M., Noimany, B., Emberley, K., Emery, B., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2507354122 · Cited by 15
Neurodegenerative Disorder Risk in Krabbe Disease Carriers
Vantaggiato, L., Shaba, E., Carleo, A., Bezzini, D., Pannuzzo, G., Luddi, A., Piomboni, P., Bini, L., & Bianchi, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113537 · Cited by 14
Ninj2 regulates Schwann cells development by interfering laminin-integrin signaling
Sun, Y., Chen, X. '., Yue, C., Yang, W., Zhang, S., Ou, Z., & Chen, Y. (2022) · Theranostics · doi:10.7150/thno.76131 · Cited by 13
“Similar precocious myelination phenotype was obtained in the Cnpcre/+;Ninj2fl/fl mice at P3, another mice strain with Ninj2 knockout in glial cells (Figure 1E-G) [19].”
BackgroundNeurogenic marker expression in differentiating human adipose derived adult mesenchymal stem cells
Pelegri, N. G., MILTHORPE, B. K., Gorrie, C. A., & Santos, J. (2023) · Stem Cell Investigation · doi:10.21037/sci-2022-015 · Cited by 14
“This enzyme is necessary for oligodendrocyte development and branching and plays a critical role in early myelin formation (29) and neuronal health more generally (34).”
BackgroundProtective effect of mulberry flavonoids on sciatic nerve in alloxan-induced diabetic rats
Ma, S., Dong-lian, L., Deng, J., & Yan-juan, P. (2014) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s1984-82502014000400012 · Cited by 13
Downregulation of CNPase in a MeCP2 deficient mouse model of Rett syndrome
Wu, W., Gu, W., Xu, X., Shang, S., & Zhao, Z. (2012) · Neurological Research · doi:10.1179/016164111x13214359296301 · Cited by 14
Bull, S.-J., Bin, J. M., Beaumont, É., Boutet, A., Krimpenfort, P., Sadikot, A. F., & Kennedy, T. E. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0448-14.2014 · Cited by 13
Proteomic Profiling of the Insoluble Pellets of the Transected Rat Spinal Cord
Yan, X., Liu, T., Yang, S., Ding, R., Liu, Y., Zhang, X., Que, H., Wei, K., Luo, Z., & Liu, S. (2009) · Journal of Neurotrauma · doi:10.1089/neu.2008.0533 · Cited by 13
“CNP1 is necessary to myelinogenesis by regulating cytoplasmic microtubule distribution (Bifulco et al., 2002; Lappe-Siefke et al., 2003).”
Chew, L., DeBoy, C. A., & Senatorov, V. V. (2014) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2014.08.017 · Cited by 14
Peripheral Inflammation and Demyelinating Diseases
Murta, V., & Ferrari, C. C. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-40764-7_13 · Cited by 15
Siems, S. B., Gargareta, V., Schadt, L. C., Gastaldi, V. D., Jung, R. B., Piepkorn, L., Casaccia, P., Sun, T., Jahn, O., & Werner, H. B. (2024) · Glia · doi:10.1002/glia.24614 · Cited by 12
Conditional Mutagenesis in Oligodendrocyte Lineage Cells
Goebbels, S., & Nave, K. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9072-6_15 · Cited by 12
Self-citation
Metadata
- Authors
- Lappe-Siefke, C., Goebbels, S., Gravel, M., Nicksch, E., Lee, J., Braun, P. E., Griffiths, I. R., & Nave, K.-A.
- Affiliations
- Max Planck Institute of Experimental Medicine (DE)
- Max Planck Society (DE)
- McGill University (CA)
- University of Glasgow (GB)
- Corresponding author
- Nave, Klaus-Armin
- Venue
- Nature Genetics
- Published
- 2003-02-18
- Volume
- 33
- Issue
- 3
- Pages
- 366-374
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2000485285
- Cited by
- 1,036
- References
- 52
- Citations by year
- 2026: 28 · 2025: 38 · 2024: 46 · 2023: 51 · 2022: 38 · 2021: 40 · 2020: 48 · 2019: 52 · 2018: 48 · 2017: 53 · 2016: 44 · 2015: 57 · 2014: 56 · 2013: 49 · 2012: 51
- FWCI
- 24.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- Cnp1, cyclic nucleotide phosphodiesterase, oligodendrocytes, myelination, axonal swellings, neurodegeneration, hydrocephalus, myelin ultrastructure, axonal integrity, multiple sclerosis
- MeSH terms
- Animals, Axons, Cytoskeleton, Female, Heterozygote, Homozygote, Male, Mice, Inbred C57BL, Myelin Sheath, Nerve Degeneration, Oligodendroglia, Phenotype, 2',3'-Cyclic-Nucleotide Phosphodiesterases, Mice, Knockout, Gene Targeting, Heredodegenerative Disorders, Nervous System, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.